[Complement inhibitors: A global point of view]

Rev Med Interne. 2022 Dec;43(12):703-712. doi: 10.1016/j.revmed.2022.09.004. Epub 2022 Nov 21.
[Article in French]

Abstract

Innate immunity, and more specifically the complement system, has arised renewed interest in the medical field in recent years. Many innovative complement-inhibiting drugs have appeared, acting at various levels of the complement cascade. These drugs have made it possible to transform poor prognosis of certain diseases. Many of them are currently being tested in clinical trials for various indications. Many questions appear about their optimal use and their future indications. This article recalls the fundamental role of the complement system in the human organism. It then discusses the diseases in which the complement is involved on the pathophysiological level. The third part details the different classes of complement inhibitors and briefly recalls the indications for which these treatments seem the most promising. Finally, we end with a discussion that highlights the different aspects and questions induced by these new treatments.

Keywords: Complement; Complement inhibitor; Complément; Inhibiteur du complément; Innovant; Innovating.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Complement Inactivating Agents* / pharmacology
  • Complement Inactivating Agents* / therapeutic use
  • Humans
  • Immunity, Innate*

Substances

  • Complement Inactivating Agents